Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects

C.L.M. Krieckaert*, S.C. Nair, M.T. Nurmohamed, C.J.J. van Dongen, W.F. Lems, F.P.J.G. Lafeber, J.W.J. Bijlsma, Hendrik Koffijberg, G. Wolbink, P.M.J. Welsing

*Corresponding author for this work

Research output: Contribution to journalArticleAcademic

53 Citations (Scopus)

Fingerprint Dive into the research topics of 'Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds